Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma

Gynecologic Oncology

Volumn 87, Issue 1, 2002, Pages 84-89

  Kim, Young Tae ^a   Park, Sang Won ^b   Kim, Jae Wook ^b  

^a Yonsei University College of Medicine   (South Korea)

^b CHA University   (South Korea)

Author keywords

Cervical cancer; EGFR; Enzyme immunoassay; Prognosis

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA;

EID: 0036920080     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6803     Document Type: Article

References (37)

1. Hynes NE, Stern DF. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1994;1198:165-84.
2. Cowley GP, Smith JA, Gusterson BA. Increased EGF receptors on human squamous carcinoma cell lines. Br J Cancer 1986;53:223-29.
3. Fisher DA, Lakshmanan J. Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev 1990;11:418-42.
4. Ozanne B, Richards CS, Hendler F, Burns D, Gusterson B. Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas. J Pathol 1986;149:9-14.
5. Stoscheck CM, King LE Jr. Role of epidermal growth factor in carcino-genesis. Cancer Res 1986;46:1030-37.
6. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 1987;56:881-14.
7. Cohen S. The epidermal growth factor (EGF). Cancer 1983;51:1787-1791.
8. Yarden Y, Ullrich A. Growth factor receptor tyrosine kinases. Annu Rev Biochem 1988;57:443-78.
9. Fukushige S, Matsubara K, Yoshida M. Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol Cell Biol 1986;6:955-58.
10. Shoyab M, Plowman GD, McDonald VL, Bradley JG, Todaro GJ. Structure and function of human amphiregulin: A member of the epidermal growth factor family. Science 1989;243:1074-76.
11. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A hepar in-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991;251:936-39.
12. Schreiber AB, Libermann TA, Lax I, Yarden Y, Schlessinger J. Biological role of epidermal growth factor-receptor clustering. Investigation with monoclonal anti-receptor antibodies. J Biol Chem 1983;258:846-53.
13. Battaglia F, Scambia G, Benedetti Panici P. Epidermal growth factor receptor expression in gynecological malignancies. Gynecol Obstet Invest 1989;27:42-44.
14. Kohler M, Janz I, Wintzer HO, Wagner E, Bauknecht T. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. Anticancer Res 1989; 9:1537-47.
15. Berchuck A, Rodriguez G, Kamel A, Soper JT, Clarke-Pearson DL, Bast RC Jr. Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. Obstet Gynecol 1990;76:381-87.
16. Gullick WJ. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 1991;47:87-98.
17. van Dam PA, Lowe DG, Watson JV. Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tract. Gynecol Oncol 1991;42:256-64.
18. Kim JW, Kim YT, Kim DK. Correlation between EGFR and c-erbB-2 oncoprotein status and response to neoadjuvant chemotherapy in cervical carcinoma. Yonsei Med J 1999;40:207-14.
19. Kim JW, Kim YT, Kim DK, Song CH, Lee JW. Expression of epidermal growth factor receptor in carcinoma of the cervix. Gynecol Oncol 1996;60:283-87.
20. Nicholson RI, McClelland RA, Gee JM. Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy. Breast Cancer Res Treat 1994;29:117-25.
21. Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer 2001;37 Suppl 4:S9-15.
22. Scambia G, Benedetti Panici P, Battaglia F. Significance of epidermal growth factor receptor in advanced ovarian cancer. J Clin Oncol 1992;10:529-35.
23. Pfeiffer D, Stellwag B, Pfeiffer A, Borlinghaus P, Meier W, Scheidel P. Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1989;33:146-50.
24. Kristensen GB, Holm R, Abeler VM, Trope CG. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohis-tochemical study. Cancer 1996;78:433-40.
25. Hale RJ, Buckley CH, Gullick WJ, Fox H, Williams J, Wilcox FL. Prognostic value of epidermal growth factor receptor expression in cervical carcinoma. J Clin Pathol 1993;46:149-53.
26. Kersemaekers AM, Fleuren GJ, Kenter GG. Oncogene alterations in carcinomas of the uterine cervix: Overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res 1999;5:577-86.
27. Hayashi Y, Hachisuga T, Iwasaka T. Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement. Gynecol Oncol 1991;40:147-51.
28. Scambia G, Ferrandina G, Distefano M, D'Agostino G, Benedetti-Panici P, Mancuso S. Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer. Cancer Lett 1998;123:135-39.
29. Oka K, Nakano T, Arai T. Expression of cathepsin D and epidermal growth factor receptor in stage III cervical carcinoma. Intl J Gynecol Cancer 1997;7:122-26.
30. Lowry OH, Rosebrough NJJ, Farr AL. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-69.
31. Waterfield MD, Mayes EL, Stroobant P. A monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochem 1982;20:149-61.
32. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
33. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:187-20.
34. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31, 1.
35. Bosch FX. Trends in cervical cancer mortality. J Epidemiol Community Health 1999;53:392.
36. Dell G, Gaston K. Human papillomaviruses and their role in cervical cancer. Cell Mol Life Sci 2001;58:1923-42.
37. Beger M, Butz K, Denk C, Williams T, Hurst HC, Hoppe-Seyler F. Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription. J Mol Med 2001;79:314-20.